Molnupiravir, manufactured by Merck & Co, received emergency use authorization last week.
(CDMX – COFEPRIS) – The Federal Commission for Protection against Health Risks warned on Friday about the illegal marketing of the drug molnupiravir, the pill against COVID-19 manufactured by Merck & Co.
This drug received emergency use approval from Cofepris just a week ago, on January 7.
The agency explained that complaints had been received about products being marketed as molnupiravir, so it reminded no one can sell the drug under the emergency use authorization.
The presentations that are being sold fraudulently are:
– Mpiravir, from Merit laboratory, in white box presentation with green and yellow lines. It has an expiration date of October 2023 and contains 40 capsules of 200 milligrams.
– Molaz, from Azista, in a white box with orange and purple lines; it contains 200 mg capsules and 40 capsules; it is offered as an over-the-counter product.
The Yucatan Times
Newsroom
